Kidney Aspects of the Lung Cancer

Yu.V. Dumanskyi, O.V. Syniachenko, O.Yu. Stoliarova, V.A. Stepko, Ye.D. Yehudyna

Abstract


Metastases in the kidney, perirenal retroperitoneal lymph nodes and adrenal glands occur in 2, 2, and 3 % of patients with lung cancer, respectively, and acute tubulointerstitial nephritis develops in 6 % of cases of radiochemotherapy complications, which impairs the survival of patients, depends on the shape and location of the primary tumor process, the degree of its differentiation, integrated severity and the use of anticancer drugs (taxanes) in combined treatment.


Keywords


cancer; lung; kidneys

References


Agrawal A, Sahni S, Iftikhar A, Talwar A. Pulmonary manifestations of renal cell carcinoma. Respir Med 2015;9(10):142-9. doi: 10.1016/j.rmed.2015.10.002.

Ahmadzadeh A, Shahbazian H, Safapour N, Tulabi M, Zandifar S. Comparison between the effects of one-day treatment regimen with cisplatin on renal function and various biochemical parameters in patients with gastric and lung cancer compared with two-days divided cisplatin treatment regimen. J Renal Inj Prev 2015;4(3):87-91. doi: 10.12861/jrip.2015.17.

Boca C, Leonte D, Radulescu M, Jentimir I, Fotache G, Mateescu T. Synchronous primary lung cancer and controlateral pulmonary renal cell carcinoma metastases. Pneumologia 2015;64(2):41-3.

Ceniceros L, Aristu J, Castanon E, Rolfo C, Legaspi J, Olarte A, Valtuena G, Moreno M, Gil-Bazo I. Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients. Clin Transl Oncol 2015;55(8):213-9.

Chaari A, Ben Nasr S, Labidi S, Afrit M, Boussen H. Metastatic non-small cell lung cancer: a tunisian retrospective study about 100 cases. Tunis Med 2015;93(5):294-6.

Grаdalska-Lampart M, Karczmarek-Borowska B, Radziszewska AU. Lung cancer in Podkarpackie region in the years 2002-2011. Pneumonol Alergol Pol 2015;83(2):109-19. doi: 10.5603/PiAP.2015.0018.

Kukulj S, Popovic F, Budimir B, Drpa G, Serdarevic M, Polic-Vizintin M. Smoking behaviors and lung cancer epidemiology: a cohort study. Psychiatr Danub 2014;26(3):485-9.

Mao K, Liu F, Liu X, Khuri FR, Marcus AI, Li M, Zhou W. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression. Lung Cancer 2015;88(2):131-8. doi: 10.1016/j.lungcan.2015.02.017.

Qu HM, Bai YN, Cheng N, Dai M, Zheng TZ, Wang D, Li HY, Hu XB, Li JS, Ren XW, Shang H. Trend analysis of cancer mortality in the jinchang cohort, China, 2001-2010. Biomed Environ Sci 2015;28(5)364-9. doi: 10.3967/bes2015.050.

Shinke H, Masuda S, Togashi Y, Ikemi Y, Ozawa A, Sato T, Kim YH, Mishima M, Ichimura T, Bonventre JV, Matsubara K. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother Pharmacol 2015;76(5):989-96. doi: 10.1007/s00280-015-2880-y.

Yan F, Duan J, Wang J. Mechanism of platinum derivatives induced kidney injury. Zhongguo Fei Ai Za Zhi 2015;18(9):580-6. doi: 10.3779/j.issn.1009-3419.2015.09.09.

Ying L, Zhu Z, Xu Z, He T, Li E, Guo Z, Liu F, Jiang C, Wang Q. Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung cancer A549 cells by up-regulating the PI3K/Akt and GRP78 signaling on a microfluidic platform. PLoS One 2015;10(6):0129593. doi: 10.1371/journal.pone.0129593.




DOI: https://doi.org/10.22141/2307-1257.0.1.15.2016.71480

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru